Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations

Antibody–drug conjugates (ADCs) represent a novel and evolving class of antineoplastic agents, constituted by monoclonal antibody linked to biologically active drugs, delivering cytotoxic compounds at the tumor site, reducing the likelihood of systemic exposure and toxicity. They are generally well...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Arienzo, Andrea, Verrazzo, Annarita, Pagliuca, Martina, Napolitano, Fabiana, Parola, Sara, Viggiani, Martina, Caputo, Roberta, Puglisi, Fabio, Giuliano, Mario, Del Mastro, Lucia, Arpino, Grazia, De Laurentiis, Michelino, Montemurro, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404866/
https://www.ncbi.nlm.nih.gov/pubmed/37554126
http://dx.doi.org/10.1016/j.eclinm.2023.102113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404866/
https://www.ncbi.nlm.nih.gov/pubmed/37554126
http://dx.doi.org/10.1016/j.eclinm.2023.102113

Ejemplares similares